Skip to main content
. 2022 Apr 14;2022:8943292. doi: 10.1155/2022/8943292

Table 3.

Univariate analysis of BTP incidence among demographic data.

BTP (%) χ 2 P BTP (%) χ 2 P
Age 18–64 57.2 10.641 <0.001 Liver and cholecyst cancer Yes 62.7 1.810 0.177
≧65 44.4 No 53

Gender Male 56.5 3.781 0.052 Lung cancer Yes 50.8 1.064 0.302
Female 49.7 No 54.8

Education level Primary 47.2 7.4 0.025 Breast cancer Yes 47.7 0.653 0.419
Middle 57.8
Advanced 53.3 No 54

Spouse Yes 54 0.923 0.337 Colorectal cancer Yes 57.3 0.542 0.461
No 45.7 No 53.2

Living place City 52.1 0.626 0.429 Cervical cancer Yes 42.1 3.281 0.07
Country 54.9 No 54.5

BMI 1 55 0.686 0.877 Head and neck cancer Yes 55.8 0.167 0.682
2 52.8 No 53.4
3 55.4 Fatigue Yes 60.9 7.428 0.006
4 50 No 50.5

Metastasis number 0 47.9 9.45 0.024 Pain Yes 56.6 37.497 <0.001
1 56.7 No 14.3
2 57.3 Constipation Yes 65.2 15.432 <0.001
≧3 62.8 No 49.5

Bone metastasis Yes 59.3 4.6 0.032 Anorexia Yes 66.3 29.665 <0.001
No 51.1 No 46.4

Lymph metastasis Yes 57.8 1.27 0.259 Sleep disorder Yes 65.6 23.764 <0.001
No 52.7 No 47.4

Liver metastasis Yes 62.3 4.344 0.037 Bloating Yes 57.5 0.753 0.386
No 52.1 No 53

PS Good 52.4 1.087 0.297 Cough Yes 50.6 0.853 0.356
Poor 56.4 No 54.5

Distress score Severe 60 0.249 0.618 Nausea and vomiting Yes 58.3 2.505 0.114
Mild 53.5 No 52

Barthel index Severe 51.6 1.963 0.58 Dyspnea Yes 58.8 1.938 0.164
Moderate 57
Slight 52.5
Independent 50 No 52.5

Background pain level 1 44.7 52.282 <0.001 Symptom number ≦4 45.5 33.764 <0.001
2 73.7 5–9 65.5
3 75 ≧10 73.3